Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04496544 · ClinicalTrials.gov registry record
Safety Assessment of Femoropopliteal Endovascular Treatment With PAclitaxel-coated Devices (SAFE-PAD Study)
A clinical trial, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- 168,553
- Enrollment target
NCT04496544 is a clinical trial that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 168,553 participants.
The verdict
NCT04496544 has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- 168,553 participants
- Enrollment target
Study Summary
The SAFE-PAD Study aims to evaluate the long-term safety of paclitaxel-coated devices compared with non-paclitaxel-coated devices for femoropopliteal artery revascularization among a broad, real-world population of patients with peripheral artery disease. This multi-year analysis aims to create an ongoing mechanism to evaluate the safety of paclitaxel-coated devices in real world practice. The null hypothesis is that the paclitaxel-coated devices are associated with an increase in mortality relative to the non-drug-coated devices beyond an acceptable magnitude (i.e. the non-inferiority margin), and the alternative hypothesis is that paclitaxel-coated devices are not associated with an increase in mortality relative to the non-drug-coated devices beyond the non-inferiority margin.
Interventions
- OTHER Retrospective data collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 168,553 participants |
| Start Date | 2020-07-01 |
| Est. Completion | 2024-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04496544
The ClinicalTrials.gov registry entry for NCT04496544 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 168,553 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Retrospective data collection is the first listed.
NCT04496544 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04496544 about?
NCT04496544 is a clinical study titled "Safety Assessment of Femoropopliteal Endovascular Treatment With PAclitaxel-coated Devices (SAFE-PAD Study)". The SAFE-PAD Study aims to evaluate the long-term safety of paclitaxel-coated devices compared with non-paclitaxel-coated devices for femoropopliteal artery revascularization among a broad, real-world population of patients with peripheral artery disease. This multi-year analysis aims to create an o...
What is the current status of trial NCT04496544?
This trial is currently completed. The enrollment target is 168,553 participants. The study started on 2020-07-01. Estimated completion is 2024-06-30.
What interventions are being tested in trial NCT04496544?
The interventions under investigation include: Retrospective data collection (OTHER).
Who is sponsoring clinical trial NCT04496544?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.